Fri, May 12, 2023
Thu, May 11, 2023
Wed, May 10, 2023

Jonathan Block Maintained (ARQT) at Strong Buy with Decreased Target to $33 on, May 11th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-33-on-may-11th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jonathan Block of Goldman Sachs, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy with Decreased Target from $44 to $33 on, May 11th, 2023.

Jonathan has made no other calls on ARQT in the last 4 months.



There are 5 other peers that have a rating on ARQT. Out of the 5 peers that are also analyzing ARQT, 0 agree with Jonathan's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Jonathan


  • Nigel Dally of "Morgan Stanley" Maintained at Buy with Decreased Target to $45 on, Wednesday, May 10th, 2023
  • Uy Ear of "Mizuho" Maintained at Strong Buy with Decreased Target to $57 on, Wednesday, May 10th, 2023
  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $24 on, Wednesday, April 19th, 2023
  • Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Decreased Target to $45 on, Wednesday, March 29th, 2023
  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $50 on, Wednesday, March 1st, 2023

Publication Contributing Sources